Christopher Henney

2011

In 2011, Christopher Henney earned a total compensation of $203K as Acting principal executive officer; Chairman of the Board of Directors at Oncothyreon, a 577% increase compared to previous year.

Compensation breakdown

Stock Awards$203,000
Total$203,000

Henney received $203K in stock awards, accounting for 100% of the total pay in 2011.

Rankings

In 2011, Christopher Henney's compensation ranked 10,126th out of 10,747 executives tracked by ExecPay. In other words, Henney earned more than 5.8% of executives.

ClassificationRankingPercentile
All
10,126
out of 10,747
6th
Division
Services
1,515
out of 1,597
5th
Major group
Engineering, Accounting, Research, Management, And Related Services
166
out of 172
4th
Industry group
Research, Development, And Testing Services
45
out of 45
0th
Industry
Commercial Physical and Biological Research
41
out of 41
0th
Source: SEC filing on April 24, 2012.

Henney's colleagues

We found five more compensation records of executives who worked with Christopher Henney at Oncothyreon in 2011.

2011

Robert Kirkman

Oncothyreon

Chief Executive Officer

2011

Diana Hausman

Oncothyreon

Chief Medical Officer

2011

Gary Christianson

Oncothyreon

Chief Operating Officer

2011

Julia Eastland

Oncothyreon

Chief Financial Officer

2011

Scott Peterson

Oncothyreon

Chief Scientific Officer

You may also like